Antoni Riera‐Mestre

Rivaroxaban Versus Vitamin K Antagonist in Antiphospholipid Syndrome

Josep Ordi‐Ros, Luís Sáez-Comet, Mercedes Pérez-Conesa et al. · Annals of Internal Medicine · 2019 · 298 citations

Genetic Screening for TLR7 Variants in Young and Previously Healthy Men With Severe COVID-19

Xavier Solanich, Gardenia Vargas‐Parra, Caspar I. van der Made et al. · Frontiers in Immunology · 2021 · 115 citations · Full text

Pre-existing Autoantibodies Neutralizing High Concentrations of Type I Interferons in Almost 10% of COVID-19 Patients Admitted to Intensive Care in Barcelona

Xavier Solanich, Raül Rigo‐Bonnin, Victor-David Gumucio et al. · Journal of Clinical Immunology · 2021 · 102 citations · Full text

PI3K (Phosphatidylinositol 3-Kinase) Activation and Endothelial Cell Proliferation in Patients with Hemorrhagic Hereditary Telangiectasia Type 1

Adriana Iriarte, Pau Cerdà, José María Mora et al. · Cells · 2019 · 49 citations · Full text

Hht1 Patients, Phosphatidylinositol 3-Kinase, Hematology +15

Beneficial effect of corticosteroids in preventing mortality in patients receiving tocilizumab to treat severe COVID-19 illness

Manuel Rubio‐Rivas, Mar Ronda, Ariadna Padullés et al. · International Journal of Infectious Diseases · 2020 · 43 citations · Full text

Long Covid, Beneficial Effect, Immunology +5